Apotheek Baert S. SPRL
Apotheek Baert S. reported total assets of 194,387 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jan 2026).
The score of Apotheek Baert S. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -28 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Baert S.'s annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 06 Jan 2026
- Year ended 30 Jun 2024filed on 30 Jan 2025
- Year ended 30 Jun 2023filed on 29 Jan 2024
- Year ended 30 Jun 2022filed on 16 Dec 2022
- Year ended 30 Jun 2021filed on 22 Nov 2022
Apotheek Baert S.'s financial analysis
- Solvency-21.5%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Baert S.
Apotheek Baert S.'s publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0860.904.197
- VAT number
- BE0860904197
- Peppol
- Registered · 0208:0860904197 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 07 Oct 2003
- Registered office
- 8000 Bruges
- Latest accounts
- 2025 · filed on 06 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Baert S. (SPRL) has been based in Bruges since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 1,185 € and equity of −41,829 €; its revenue is not published. Its solvency stands at -21.5%, below the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Baert S.
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie des Viaducs Retail sale of pharmaceutical products Mons · balance sheet 97,079 €
- Promeditech Retail sale of pharmaceutical products Brussels · balance sheet 186,985 €
- Sentelys Pharma Retail sale of pharmaceutical products Koekelberg · balance sheet 225,328 €
- BMVA Retail sale of pharmaceutical products Bornem · balance sheet 167,342 €
- Babay Pharma Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 246,996 €
- SOBEN Pharma Robeerst Retail sale of pharmaceutical products Esneux · balance sheet 282,954 €
- Apoteek Lefever-Feyaerts Retail sale of pharmaceutical products Overijse · balance sheet 283,638 €
- Zorgapotheek Maldegem Retail sale of pharmaceutical products Maldegem · balance sheet 304,353 €
Frequently asked questions about Apotheek Baert S.
What is the revenue of Apotheek Baert S.?
Apotheek Baert S. files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Baert S.?
In Belgium, the VAT number is the company number prefixed with BE: BE0860904197 for Apotheek Baert S., if the company is VAT-registered. Its company number (CBE) is 0860.904.197.
Where is the registered office of Apotheek Baert S.?
According to the CBE register, the registered office of Apotheek Baert S. is in 8000 Bruges.
What is the equity of Apotheek Baert S.?
At the close of the 2025 financial year, the equity of Apotheek Baert S. amounts to -41,829 €, a solvency of -21.5% of total assets.
Who manages Apotheek Baert S.?
The register lists 1 active mandates at Apotheek Baert S.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Baert S.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →